S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
The purposes of the study were to obtain further information about the optimal dose and the
efficacy of Keppra in daily clinical practice, and to confirm the favorable safety and
tolerability profiles of the drug observed during clinical development.